The Case for Diluting Your Blood (Yes, Really)

There's a weird little corner of longevity science built around a strange question: what if some of what makes us age isn't about what our cells are missing, but about what's accumulating in our blood?

That question comes from mouse experiments where scientists surgically joined young and old mice so they shared a blood supply. The old mice got noticeably healthier tissue function. For years, everyone assumed this was because young blood was delivering something magical. But a UC Berkeley lab led by Irina Conboy ran the experiment differently. Instead of adding young blood, they just removed old plasma and replaced it with a neutral saline-albumin mix, no young blood involved. The old mice still improved. That flipped the whole hypothesis: maybe it's not what young blood gives you, it's what old blood is dragging you down with.

That idea has a name in medicine: therapeutic plasma exchange, or TPE. It's not new. It's been used for decades to treat things like Guillain-Barré syndrome and myasthenia gravis, where the goal is to physically filter harmful antibodies out of the blood. What's new is using the same tool on healthy people, on the theory that diluting decades of accumulated inflammatory junk might do for us what it did for those mice.

The Berkeley team eventually tested this in actual humans. In a 2022 study published in GeroScience, researchers ran a group of participants through several rounds of TPE and found it produced a real, measurable shift toward a "younger" proteomic profile, including reduced markers of cellular senescence and a more youthful balance across several inflammatory signaling pathways. A follow-up randomized, placebo-controlled study in 2025, published in Aging Cell, went further and looked at biological age markers directly, including epigenetic clocks, in adults over 50. That one found real improvements compared to placebo. This isn't a mouse study anymore. It's controlled, peer-reviewed, human data.

That's why you're starting to see TPE show up in longevity clinics and get name-dropped in the same conversations as NAD+ IVs and continuous glucose monitors. It's grounded in a real, testable mechanism, and it now has actual clinical trial data behind it, which is more than most things in the wellness aisle can claim.

Here's the honest part, though. These studies are still small, and the follow-up windows are still short. A shift in a biological age marker is a real result, but it's not the same as proof that people who do this live longer or get sick less often. Nobody has run the decades-long study that would answer that question, and TPE for anti-aging is still considered off-label and experimental, not an approved use of the procedure. It also isn't casual: it requires IV access, takes a few hours per session, usually over a series of visits, and carries the same real risks as any apheresis procedure, things like infection, allergic reaction to the replacement fluid, and electrolyte shifts.

So where does that leave things? Somewhere genuinely interesting. Not proven, not nothing. A real mechanism, real early human data, and a lot of open questions about durability, frequency, and who actually benefits most. That's a good place for a promising idea to sit, and exactly why it's worth watching closely instead of writing off or buying into completely.

This article is for informational purposes and is not medical advice. Talk to a physician before pursuing any medical procedure, including TPE.

Sources:

Mehdipour et al., “Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin,” Aging, 2020
https://pubmed.ncbi.nlm.nih.gov/32474458/

Kim et al., “Old plasma dilution reduces human biological age: a clinical study,” GeroScience, 2022
https://pubmed.ncbi.nlm.nih.gov/35999337/

Fuentealba et al., “Multi-Omics Analysis Reveals Biomarkers That Contribute to Biological Age Rejuvenation in Response to Single-Blinded Randomized Placebo-Controlled Therapeutic Plasma Exchange,” Aging Cell, 2025
https://pubmed.ncbi.nlm.nih.gov/40424097/

ClinicalTrials.gov: NCT06534450
https://clinicaltrials.gov/study/NCT06534450